SEC FORM 4
$38.38
Karyopharm Therapeutics Inc. (KPTI)
Sale of 19 shares at $2.02 per share.
Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-380404 · filed 2026-09-02 · View filing →